JOSEPH FAKOURI: Open Payments
NPI 1225148315 · MONTICELLO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 13 payments from 8 companies in 2025. Trend: 2023 $536 · 2024 $453 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| PFIZER INC. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Kerendia, TRELEGY ELLIPTA, ELIQUIS, CAPLYTA, Ozempic, NURTEC ODT, Dexcom G6 Transmitter, VRAYLAR.
Industry payments across AR — which companies pay providers there.
